The side effects of radiotherapy on the digestive system

Written by: Dr Shameer Mehta
Published: | Updated: 28/08/2019
Edited by: Laura Burgess

If your pelvic cancer (cervical, prostate, bladder or bowel) is being treated with radiotherapy, perhaps you are experiencing some unfortunate secondary symptoms, such as bloating, diarrhoea, constipation or rectal bleeding, which is known as pelvic radiation disease. Here leading gastroenterologist Dr Shameer Mehta explains the possible side effects that radiotherapy may have on the gut and how long they may last.

 

How does the gut work?

The ability of the gut to function correctly is more sophisticated than we previously imagined. It relies on various factors, including:

  • The balance of good and bad bacteria
  • Adequate amounts of digestive juices
  • The nervous system providing the right signals
  • A good blood supply
  • An effective gut barrier against harmful bacteria
     

How does radiotherapy affect the digestive system?

Radiotherapy has the potential to affect many of those mentioned above, which in turn leads to abnormal functioning of the gut.

The principle effects of radiation have so far been found to be reduced blood flow to the gut and consequent scarring of the bowel wall. Some studies have also suggested an imbalance of bacteria within the bowel caused directly by radiotherapy. The bowel wall can respond to reduced blood flow by attempting to form new blood vessels.

Unfortunately, these new blood vessels are more fragile than the original vessels and are much more prone to bleeding. When this occurs in the lower bowel (rectum) this can cause obvious bleeding which can be distressing for patients and can require treatment.

It is likely that damage to the gut lining and scarring within the small bowel wall together with a possible bacterial imbalance, are the main causes of symptoms in patients suffering from pelvic radiation disease.

These radiotherapy effects are currently irreversible, however, these changes also lead to a number of secondary syndromes, which can often be successfully treated if investigated appropriately.
 

How long do these side effects of radiation last?

Most patients will experience some degree of bowel symptoms during radiotherapy, although these usually settle down after a few weeks. It is important to check for and to treat infection as this is very common during this period.

Patients who suffer from more long term side effects usually begin to experience these a few months after the end of radiotherapy treatment, although they can also occur some years later. The duration of these side effects can vary, for example, men with rectal bleeding due to radiation damage after prostate therapy usually start to develop this one year after treatment, with symptoms lasting for approximately two years.

Other patients will instead experience symptoms such as bloating, diarrhoea or constipation. It is often possible to treat symptoms successfully, once appropriate medical help is sought. If left untreated, however, these side effects can persist for years.
 

Will the guts ever recover from pelvic radiation disease?

Whilst it is thought that the various effects of radiotherapy on the bowel wall are irreversible, it is entirely possible for the symptoms of pelvic radiation disease to be treated successfully. Improving symptoms also often leads to an improvement in overall quality of life for patients suffering from this condition.

This does, however, depend on having the right assessment and set of tests to allow treatments to be tailored to each individual patient.


Do not hesitate to book an appointment with Dr Mehta now to discuss any of your digestive concerns.

 

By Dr Shameer Mehta
Gastroenterology

Dr Shameer Mehta is a highly skilled and experienced gastroenterologist, based in London and specialising in pelvic radiation disease, inflammatory bowel disease (IBD) and nutritional disorders, among others.

He is one of only a few consultants who has been appointed to two London teaching hospitals: University College London Hospital and, currently, The Royal London Hospital (Barts Health NHS Trust) where he is the clinical lead for nutrition. His private practice is based at The London Digestive Centre and The Princess Grace Hospital, as well as Cleveland Clinic London where is also the clinical lead for nutrition. He maintains a strong interest in research and education, both nationally and internationally and is an honorary associate professor at University College London. He is also a passionate advocate for shared decision making between patient and physician and believes a healthy gut is vital for overall well-being. 

He began his medical training at Guy’s and St Thomas’s Hospitals, before starting his higher specialist training in North East London in gastroenterology. Following this, he then went on to complete a fellowship at Queen Mary’s and the Blizard Institute in medical education and basic science research. He was designated a fellow of the Higher Education Academy in recognition of his work. His research degree (MD) in basic science examined the role that microRNAs have in the control of the epithelial to mesenchymal transition and the development of intestinal fibrosis in Chron’s disease. 

Dr Mehta’s main role is as the Lead for the Intestinal Failure Service at The Royal London Hospital, one of the largest such services in the UK. He works in a multi-disciplinary fashion providing a comprehensive treatment plan to patients with complex nutritional care and intestinal failure. He also works with patients experiencing inflammatory bowel disease (IBD), irritable bowel disease and those with gastrointestinal disorders as a consequence of their cancer treatment. He currently holds the position of clinical lead for the trust’s Nutrition and Hydration Strategy Group, which attempts to improve nutritional provisions for patients, visitors and staff. 

He has a track record of delivering high-quality research in areas including the role malnutrition in IBD, intestinal-failure associated liver disease, and pelvic radiation disease. He is invited regularly to present his findings at conferences and seminars globally and continues to publish in high-impact  medical journals.   

Dr Mehta contributes to medical education as an accredited trainer for the ESPEN Clinical Nutrition Diploma, co-chairing the UCL Master’s degree in Clinical Nutrition and Public Health, and sits on the organising committee for the UCL postgraduate course in Clinical Nutrition.  

View Profile

Overall assessment of their patients


  • Related procedures
  • Nutrition
    Food intolerance test
    Eating disorders
    Depression
    Balloon enteroscopy
    pH monitoring
    Stomach reduction
    Gastric balloon
    Colon cleanse
    Gastroscopy
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.